Skip to main content
HRMY logo
HRMY
(NASDAQ)
Harmony Biosciences Holdings, Inc.
$42.25-- (--)
Loading... - Market loading

Harmony Biosciences Holdings (HRMY) Stock Price & Financial Analysis

Harmony Biosciences Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$41.36 - $42.34
52-Week High$43.49
52-Week Low$25.52
Open$41.50
Volume659.59K
Average Volume (3M)727.27K
Market Cap2.48B
Shares Outstanding58.78M
P/E Ratio (TTM)17.05
Forward P/E17.85
Price to Sales (P/S)2.76
Price to Book (P/B)2.73
EV/EBITDA9.20
Revenue (TTM)899.11M
Net Income (TTM)145.62M
Free Cash Flow (TTM)341.79M
EPS (TTM)$2.48
Profit Margin16.20%
Operating Margin21.08%
Return on Equity (ROE)16.00%
Debt to Equity0.23
50-Day MA$37.56
200-Day MA$34.23
52-Week Change17.39%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Harmony Biosciences Holdings

What is the current stock price for HRMY?

As of the latest trading session, HRMY stock trades at $42.25. The 52-week range is $25.52–$43.49, with a day range of $41.36–$42.34.

What is the P/E ratio for HRMY?

Harmony Biosciences Holdings's trailing P/E ratio is 17.1, meaning investors pay $17.1 for every $1 of annual earnings. The forward P/E is 17.9, reflecting analyst expectations for future earnings. Harmony Biosciences Holdings operates in the Healthcare sector.

Does HRMY pay dividends?

Harmony Biosciences Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HRMY?

Based on 3 analysts, the consensus for HRMY is Buy.

What is the market cap of HRMY?

Harmony Biosciences Holdings's market capitalization is $2.48B, classifying it as a mid-cap company. Harmony Biosciences Holdings operates in the Healthcare sector within the Biotechnology industry.